Does RIVAROXABAN Cause Postmenopausal haemorrhage? 180 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 180 reports of Postmenopausal haemorrhage have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.1% of all adverse event reports for RIVAROXABAN.
180
Reports of Postmenopausal haemorrhage with RIVAROXABAN
0.1%
of all RIVAROXABAN reports
20
Deaths
140
Hospitalizations
How Dangerous Is Postmenopausal haemorrhage From RIVAROXABAN?
Of the 180 reports, 20 (11.1%) resulted in death, 140 (77.8%) required hospitalization.
Is Postmenopausal haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 180 reports have been filed with the FAERS database.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Postmenopausal haemorrhage?
ESTRADIOL (160)
ESTRADIOL\NORETHINDRONE (103)
PROGESTERONE (78)
TIRZEPATIDE (71)
ASPIRIN (67)
ADALIMUMAB (61)
ESTRADIOL\LEVONORGESTREL (45)
SEMAGLUTIDE (36)
ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE (34)
LETROZOLE (34)
Which RIVAROXABAN Alternatives Have Lower Postmenopausal haemorrhage Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM